UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM 6-K
_________________
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Commission File Number No. 001-42155
_________________
Ping An Biomedical Co., Ltd.
(Registrant’s Name)
_________________
22/F, China United Plaza
1002-1008, Tai Nan West Street
Cheung Sha Wan
Kowloon, Hong Kong
(Address of principal executive office)
_________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
In connection with an extraordinary general meeting of shareholders (the “Meeting” or “Extraordinary General Meeting”) of Ping An Biomedical Co., Ltd. (the “Company”), an exempted company incorporated under the laws of the Cayman Islands, the Company hereby furnishes the following documents:
Exhibits
|
Exhibit No. |
Description of Exhibit |
|
|
99.1 |
Notice and Proxy Statement of Extraordinary General Meeting of Shareholders |
|
|
99.2 |
||
|
99.3 |
Form of the Third Amended and Restated Memorandum of Association |
|
|
99.4 |
Form of the Fourth Amended and Restated Memorandum of Association |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
PING AN BIOMEDICAL CO., LTD. |
||||
|
Date: October 22, 2026 |
By: |
/s/ Pijun Liu |
||
|
Name: |
Pijun Liu |
|||
|
Title: |
Chairman of the Board of Directors |
|||
2